Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA advisory committee recommends approval of Forteo

July 31, 2001

Hemosol to receive funding for discovery-stage hemoglobin-based oxygen carrier

July 31, 2001

Genotropin approved in U.S. for growth failure in children born SGA

July 31, 2001

Thrombopoietin mimetics in the GSK pipeline

July 30, 2001

Inhaled insulin: a noninvasive mode of drug administration

July 30, 2001

Potent and selective PPARalpha activator useful for lowering cholesterol and triglycerides

July 30, 2001

BioMarin completes phase I clinical trials for rhASB

July 30, 2001

FDA advisory committee does not recommend approval of Symlin

July 27, 2001

Head-to-head osteoporosis fracture study comparing Evista and Fosamax

July 27, 2001

Potential antidiabetic agents presented by Ferring

July 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...